Insole Optimization for Rheumatoid Arthritis Patients
NCT07321340 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2026-02-17
Summary
Rheumatoid arthritis affects 0.5% of the population, often leading to foot deformities and pain that are difficult to treat. Management is based on controlling inflammation, adapting footwear and using custom-made insoles, all of which have proven effective. The aim of this research is to build a digital model of plantar pressures based on CT scans, in order to optimize orthopedic insoles. The study will analyze the gait of patients with and without standard insoles to identify mechanical criteria correlated with pain. The ultimate aim is to design optimized insoles, validated by a new gait analysis.
Conditions
- Rhumatoid Arthisis
Interventions
- OTHER
-
gait analysis from 3D imaging (ENSENSO)
gait analysis from 3D imaging (ENSENSO) on patients with bone geomtry 3D imaging
Sponsors & Collaborators
-
SAINBIOSE
collaborator UNKNOWN -
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2026-11-30
- Completion
- 2026-12-31
Countries
- France
Study Locations
More Related Trials
-
Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
NCT00706797 ·Status: TERMINATED ·Phase: PHASE4
-
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
NCT02531061 ·Status: COMPLETED ·Phase: NA
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Prediction Medical Device for Rheumatoid Arthritis (PREDIRA)
NCT04147026 ·Status: UNKNOWN ·Phase: NA
-
Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )
NCT03403140 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
NCT01411215 ·Status: TERMINATED
-
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
NCT00913458 ·Status: COMPLETED ·Phase: PHASE4
-
Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
NCT06528431 ·Status: RECRUITING ·Phase: PHASE4
-
Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
NCT00244556 ·Status: COMPLETED ·Phase: PHASE4
-
Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept
NCT01388608 ·Status: COMPLETED
-
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
NCT01083160 ·Status: TERMINATED
-
Very Early Versus Delayed Etanercept in Patients With RA
NCT02433184 ·Status: COMPLETED ·Phase: PHASE4
-
Pentacam Study of the Cornea in RA Patients
NCT05241639 ·Status: UNKNOWN
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers
NCT02464384 ·Status: UNKNOWN ·Phase: NA
-
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
NCT01083563 ·Status: TERMINATED
-
Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis
NCT03332719 ·Status: COMPLETED ·Phase: PHASE3
-
COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA
NCT03649061 ·Status: COMPLETED ·Phase: PHASE4
-
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
NCT01421303 ·Status: COMPLETED
-
Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis
NCT04454034 ·Status: UNKNOWN
-
Enbrel Liquid Immunogenicity Protocol
NCT00249041 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
NCT02219347 ·Status: COMPLETED ·Phase: NA
-
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
NCT01578850 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy
NCT00420303 ·Status: COMPLETED ·Phase: PHASE4